Enterprise Estonia supported the project "Development of a POC test for rapid diagnosis of pathogens (incl. COVID-19)". The project period is 01.02.2021-31.12.2023.
So far, Solis BioDyne has offered the gold standard solutions for diagnostics- RT-qPCR. Now, SARS-CoV-2 has highlighted the need for a wider variety of methods for COVID-19 analysis of patient samples.
As part of the European Regional Development Fund-supported project, Solis BioDyne is developing an innovative isothermal polymerase from which a number of reagents are being developed for use in various methods. Isothermal polymerases are increasingly used in close-up patient studies for the rapid analysis of various pathogens, allowing the analysis to be performed within 30 minutes without complex equipment.
The second goal of the project is the development of freeze-drying technology for Solis BioDyne products. Freeze-drying makes it possible to significantly extend the shelf life of products and to create new types of analytical methods. The total cost of the project is 1,368,200 €, of which the European Regional Development Fund covers up to 1,094,560€.
Valentine’s Day is a celebration of connection, commitment, love, and the dream of starting a family. However, sometimes human relationships need a little help from advances in science. In vitro fertilization (IVF), one of the most important assisted reproductive technologies, has helped millions of people start families. Yet behind every successful embryo transfer lies a deeper, invisible layer of biology - molecular precision.
It is always inspiring to see what young scientists can achieve when given the opportunity to tackle real-world challenges. This year, we supported a student team Trashformers from Lund University as they were participating in the iGEM competition. Their project’s goal was to tackle the critical issue of textile waste, specifically focusing on recycling polyester.
Have you ever sat around a table with your friends or family and just come up with the wildest ideas while having a good meal? One of Kadri’s brightest memories is exactly that — sitting around a table during lunch with her husband, sister, and brother-in-law Olev, and having the conversation that led to the start of Solis BioDyne.
Our last story ended in the middle of 2005. By then, we had spent a decade developing room-temperature stable DNA polymerases for a range of applications. In the second half of that year, we reached a turning point – we started blending and mixing to help scientists around the world reduce pipetting errors and save time.
